Keyword: Elijah Cummings

Gilead's Truvada for PrEP is only getting to about 10% of people who could benefit, according to testimony Thursday.

Two Republican lawmakers advised drugmakers to not participate in a drug pricing probe in a House committee.

A bipartisan push to lower drug prices could threaten the industry's ability to drive earnings growth, some analysts warn.

Vermont lawmakers took it upon themselves to pass a bill allowing drug imports from Canada. The catch? It'll need an OK from the Trump administration.

President Donald Trump's big speech on drug prices is set for Friday, but Democrats talked up their own proposals Thursday.

Even though drug pricing talk in Washington, D.C., has quieted somewhat, a group of lawmakers continue to beat the drum for reform.

Lawmakers in the House are kicking off an investigation of Allergan's tribal licensing deal to protect Restasis.

Rep. Elijah Cummings, D-Md., is urging President Trump to press for lower prices on Biogen's multiple sclerosis drug Zinbryta.

Lawmakers in California have approved a pricing transparency bill strongly opposed by PhRMA, sending it to Gov. Jerry Brown for a decision.

Reps. Elijah Cummings and Peter Welch announced a new probe into multiple sclerosis drug costs, digging into price hikes from seven pharmas.